Avirmax Biopharma, Inc

CA · United States · Reporting entity ID 100001455228

Total reported 2019–2025

$6K

#2,719 of 2,960 reporting companies — 0% of all reported industry payments

$2K in general payments across 16 records.

How it breaks down

General payments $2,391

Ownership & investment $3,800

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.